“Double life” of Parkinson’s protein points way to new treatments
At the heart of much research into Parkinson’s, both its causes and new forms of treatment, is a type of brain protein called alpha-synuclein. This is known to play an important role in the movement of vesicle structures that transport materials in and around cells, but new research has found it is in fact leading a “double life,” impacting on gene expression in a way that opens up new possibilities for treatment.
Tags: Parkinson’s Disease, Brain, Brigham and Women’s Hospital, MIT, Harvard
Continue reading “Double life” of Parkinson’s protein points way to new treatments